Dose, timing, schedule, and the choice of targeted epitope alter the efficacy of anti-CD22 immunotherapy in mice bearing human lymphoma xenografts

By Robert T. O’Donnell, Yunpeng Ma, Hayes C. McKnight, David Pearson and Joseph M. Tuscano

Publisher: Springer Science and Business Media LLC

Year: 2009

DOI identifier: 10.1007/s00262-009-0713-8

OAI identifier:

Provided by: MUCC (Crossref)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

https://link.springer.com/cont... (external link)